The global disposable endoscopes market size was valued at USD 1.03 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of19.8% from 2020 to 2027. Increasing incidences of Hospital-acquired Infections (HAI) due to the usage of contaminated endoscopes is one of the most pivotal factors attributed to the growth. In 2018, the American Journal of Infection Control detected microbial growth in 71.0% of the endoscope samples collected for research from three U.S. hospitals. Increasing usage of single-use endoscopes due to low cost of maintenance, cleaning, and storage is propelling the product demand. Rising prevalence of target diseases is also projected to boost the demand.
A rise in the number of product launches by leading manufacturers in North American and European countries is one of the notable trends observed in the market. For instance, in 2018, Ambu A/S received clearance on single-use colonoscopes from the U.S. Food and Drug Administration (FDA). The company is poised to increase its product portfolio with the launch of 13 new products in the next two to three years. These products will cater to the majority of applications including pulmonary, ENT, urology, duodenoscopy, colonoscopy, and gastroscopy, which will further strengthen the company’s market position. Rising concerns of regulatory bodies regarding safe usage of endoscopes to reduce the risk of patient infection is an important factor resulting in rising FDA approvals. For instance, in August 2019, FDA issued recommendations for hospitals and other facilities to shift from reusable duodenoscopes to the single-use variants.
Technological advancements and ongoing developments related to single-use endoscopes are driving the product demand. For instance, Ambu A/S launched aScope4 Broncho that provides easy navigation, high-quality images, easy usage owing to its lightweight design, and ensures safety of patients. This device is available in three different sizes. In another development in 2019, Dornier MedTech launched its single-use digital flexible ureteroscope, Axis, to solve the concern regarding cross-contamination and providing clear visualization and better image quality for urologists. In 2013, EVEXAR Medical launched its LUX range, PROCTOLUX (Proctoscope), SPECULUX (Vaginal specula), and SIGMOLUX (Sigmoidoscope), having patented Clear View system that protects the guiding light and gave a clear view of the area being examined.
Hospitals and other facilities are adopting disposable endoscopes over the reusable variants owing to reduced risk of HAI and no maintenance and reprocessing costs of the reusable endoscopes. Increasing reprocessing failures resulting in infections due to improper cleaning of the devices is also boosting the adoption and acceptance of the product. For instance, Nursing Times reported that the procedures used for endoscope reprocessing are ineffective according to the U.S. infection control experts.
In 2019, bronchoscopy held the highest share in the disposable endoscopes market. Factors, such as availability of the devices and rising bronchoscopes-related infections are driving the segment growth. Increasing respiratory infections is also expected to bode well for the segment growth. In, 2016, World Health Organization (WHO) reported 1.7 million deaths globally due to lung cancer. Efficient treatment of respiratory diseases with the help of disposable endoscopes will boost the segment growth during the forecast period.
Introduction of technologically advanced disposable bronchoscopes is anticipated to boost the segment growth. For instance, in June 2019, Valtronic launched disposable bronchoscope to prevent infections. This bronchoscope is designed with an LED light source and CMOS image sensor technology. Neoscape Inc. introduced a Neoflex bronchoscope with a built-in micro LED light source and CMOS image sensor which captures target site video images. From 2009 to 2017, Ambu A/S launched a series of aScope which includes aScope 2, aScope 3, and aScope 4 Broncho, and continues to invest in improving the product line.
Urologic endoscopy is expected to register the highest CAGR of 28.3% during the forecast period. Rising prevalence of chronic diseases like cancer, post ureteroscopy infections, FDA clearance related to single-use cystoscopies, and innovations in ureteroscopes is driving the segment growth. For instance, in 2016, Boston Scientific launched LithoVue that delivered high-quality digital visualization for the treatment of kidney, bladder, and ureter stones. Improper cleaning of reusable devices that leads to contamination is also boosting the demand. For instance, in 2016, the Association of Perioperative Registered Nurses (AORN) reported the contamination of five reusable ureteroscopes by gram-positive bacteria after ureteroscopy procedures.
In 2019, hospitals held the highest disposable endoscopes market share in terms of revenue. Increasing prevalence of hospital-acquired infections, owing to contaminated equipment is expected to drive growth. Factors such as rising reprocessing failures, growing awareness, and higher cleaning costs are resulting in the adoption of disposable endoscopes in hospitals. In 2015, FDA reported that the infections through duodenoscopes in U.S. hospitals are caused by multi-drug resistant bacteria.
Rising prevalence of chronic diseases like cancer and growing demand for low-cost endoscopy procedures are other significant factors boosting the product demand. Higher reprocessing costs and increasing demand of single-use endoscopes owing to their low maintenance cost are accelerating its demand and shifting the preference of healthcare experts for the usage of disposable ones. Moreover, medical waste generated by these devices is a threat to the environment, which may hamper the demand in future.
Clinics are anticipated to witness the highest growth and a CAGR of 28.4% during the forecast period. Increasing maintenance costs owing to the purchase of chemicals and sophisticated cleaning equipment for decontamination and rising patient-to-patient infection transmission during flexible endoscopy procedures is propelling the demand. In 2016, The Association of periOperative Registered Nurses (AORN) reported the transmission of hepatitis C virus during colonoscopy procedure in two patients due to improper endoscope reprocessing. Awareness regarding such cases is expected to fuel the product demand.
North America accounted for the highest revenue share in 2019. Increasing incidence of nosocomial infections in hospitals owing to contaminated equipment, rising prevalence of chronic diseases like cancer is propelling the demand and adoption of disposable endoscopes in this region. For instance, the National Cancer Institute, in 2018, reported more than 1.7 million new cancer cases in the U.S. which is anticipated to boost the demand of single-use endoscopes
Rising FDA approvals, availability of technologically advanced products, and high healthcare expenditure are the factors driving the growth of the North America market. For instance, in December 2019, EXALT Model D Single-use Duodenoscope introduced by Boston Scientific gained FDA 510(k) clearance. Rising awareness regarding the benefits of disposable endoscopes is leading to higher adoption among healthcare professionals in the region.
Asia Pacific is anticipated to witness the fastest growth over the forecast period. Increasing number of product approvals, growing nosocomial infections, and lack of proper reprocessing procedures are driving the regional growth. For instance, In November 2019, FDA gave clearance to The Pentax Medical Video ED34-i10T2 Duodenoscope which is installed with a disposable elevator piece to reduce the parts needed to be cleaned and reprocessed between uses. In 2016, with reference to the article published in the Open Journal of Obstetrics and Gynecology, healthcare-related infections were anticipated to be twenty times higher in developing countries than in developed countries.
New product developments to cater to the multiple application areas is the most notable strategy adopted by these market participants. Of all the market participants Ambu A/S is significantly increasing its product offering, therefore, in the next 3-4 years, Ambu A/S is poised to become one of the largest market participants. Some of the prominent players in the disposable endoscopes market include:
Boston Scientific Corporation Inc.
Flexicare Medical Ltd
Ambu A/S
Hill Rom Holdings.
OBP Medical Corporation
Report Attribute |
Details |
Market size value in 2020 |
USD 1.26 billion |
Revenue forecast in 2027 |
USD 4.45 billion |
Growth Rate |
CAGR of 19.8% from 2020 to 2027 |
Base year for estimation |
2019 |
Historical data |
2014 - 2018 |
Forecast period |
2020 – 2027 |
Quantitative units |
Revenue in USD million and CAGR from 2020 to 2027 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Application, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Russia; Japan; China; India; Australia; China; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Boston Scientific Corporation, Inc.; Flexicare Medical Ltd; Ambu A/S; Hill Rom Holdings.; OBP Medical Corporation |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2027. For the purpose of this study, Grand View Research, Inc. has segmented the global disposable endoscopes market report on the basis of application, end use, and region:
Application Outlook (Revenue, USD Million, 2014 - 2027)
Bronchoscopy
Urologic endoscopy
Arthroscopy
GI endoscopy
ENT endoscopy
Others
End-Use Outlook (Revenue, USD Million, 2014 - 2027)
Hospitals
Diagnostic Centers
Clinics
Regional Outlook (Revenue, USD Million, 2014 - 2027)
North America
The U.S.
Canada
Europe
The U.K.
Germany
Spain
France
Italy
Russia
Asia - Pacific
China
Japan
India
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East Africa
South Africa
Saudi Arabia
UAE
b. The global disposable endoscopes market size was valued at USD 1.03 billion in 2019 and is expected to reach USD 1.26 billion in 2020.
b. The global disposable endoscopes market is expected to grow at a compound annual growth rate of 19.8% from 2019 to 2027 to reach USD 4.45 billion by 2027.
b. Hospitals dominated the disposable endoscopes market with a share of 48.2% in 2019. This is attributable to the high usage of these devices in hospital settings for various diagnostic and therapeutic procedures.
b. Some key players operating in the disposable endoscopes market include Boston Scientific Corporation, Inc.; Flexicare Medical Ltd; Ambu A/S; Hill Rom Holdings.; and OBP Medical.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.